PTPRO and hepatocellular carcinoma: Moreover, PTPRO-mediated autophagy inhibits tumorigenesis in hepatocellular carcinoma (HCC) [17], and PTPRO downregulation is associated with an IL-6-driven increase in PD-L1 expression in monocytes and macrophages [18].